Target intelligence / Profile preview

Genomic DNA of Escherichia coli and Klebsiella pneumoniae

Molecular classification
Other
01

Overview

Genomic DNA of *Escherichia coli* and *Klebsiella pneumoniae* refers to the complete chromosomal DNA present within each organism. This genetic material encodes all proteins, structural RNAs, regulatory elements, and other sequence features necessary for the survival, replication, and pathogenicity of these bacteria[2][4][5]. The genome consists of both highly conserved core genes (essential for basic cell functions) and accessory genes, including those that may encode virulence factors, antibiotic resistance determinants, and strain-specific attributes[2][5]. The genomes of both species are highly diverse and dynamic, showing frequent acquisition of new genes via horizontal gene transfer, mobile genetic elements, and genetic rearrangements[2][5][7]. These entire genomic DNAs are sometimes utilized in research and diagnostics (for example, as templates for PCR or sequencing[1]), but "genomic DNA" itself is *not* a specific therapeutic target, receptor, enzyme, transporter, or druggable protein. Instead, specific genes, gene clusters, or proteins encoded *within* the genomic DNA may serve as valid therapeutic or diagnostic targets (e.g., beta-lactamase genes for antibiotic resistance, virulence operons, etc.)[1][6]. Therefore, as written, the entity "Genomic DNA of E. coli and K. pneumoniae" is incorrectly formatted and inappropriately broad to be considered a drug target. Key Issues: - The term does not refer to a single molecular entity, receptor, enzyme, or structure that can be engaged by a drug, but rather to all hereditary material of two bacterial species. - There are no standardized abbreviations, aliases, or specific families/classifications for this entirety; it is always referenced contextually, with focus usually on sub-elements or genes of interest[1][2][5]. - It does not have a defined mechanism of action, interact with drugs per se (drugs target gene products), nor is it associated with specific biomarkers or safety concerns in the way proteins or defined biomolecules are. In summary, *genomic DNA of E. coli and K. pneumoniae* is not a therapeutically actionable target and the query likely contains an error in target granularity or specificity. Proper targets require specification at the level of genes, proteins, operons, or molecular pathways encoded by this genomic DNA.

02

Biological functions

Other
03

Disease associations

Infection

Beyond the preview

Go deeper on Genomic DNA of Escherichia coli and Klebsiella pneumoniae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomic DNA of Escherichia coli and Klebsiella pneumoniae.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call